An authentic 1980s polaroid photograph of nature, depicting a path leading through a lush forest and mountains, taken on a vintage instant camera with a distinct warm orange cast.

Building a software product in the biotechnology and life sciences space has historically been slow and prohibitively expensive. Navigating database configurations, cloud deployments, and strict regulatory validation (GxP) often drains a startup’s early capital before they can even get their product into the hands of clinical researchers or patients.

Traditionally, early-stage companies are forced to choose between two paths: hire expensive traditional software consulting agencies that charge high hourly rates, or rush recruitment for full-time engineers before their product-market fit is defined.

At Saram Consulting, we are introducing a third way: Equity-Based AI Partnerships.

Aligning Incentives with Value

We believe that the transactional, hourly software consulting model is fundamentally misaligned with early innovation. High hourly rates encourage vendors to build slowly, whereas startups need to build fast, pivot quickly, and iterate.

With our equity-based model, we eliminate upfront cash engineering fees entirely for select high-impact projects. Instead, we write code and build your application in exchange for equity and/or profit-sharing partnerships. By doing this, we align our success directly with yours. We aren’t just vendor-contractors; we act as your dedicated co-founders and technology partners.

Unprecedented Speed, Uncompromised Compliance

By leveraging our state-of-the-art AI coding agents combined with automated, continuous verification validation pipelines, we build custom, production-grade applications at a fraction of the time of traditional teams.

Furthermore, we do not compromise on security or compliance. Every build is automatically tested against FDA 21 CFR Part 11 and GxP data integrity standards, ensuring that your software is auditable and ready for clinical and commercial scaling from day one.

What We Look For in Partners

Because this model requires a deep commitment of our engineering resources, we select only a handful of partners each year. We look for:

  1. High-Impact Science: Teams with strong scientific backing, clear domain expertise, and a unique approach to solving big challenges in therapeutics, digital health, or clinical operations.
  2. Clear Product Vision: Founders who understand the problem space deeply and have a clear definition of what their initial product needs to achieve.
  3. AI as a Core Catalyst: Applications where artificial intelligence, data workflows, or automated agent pipelines are central to the value proposition.

If you have a biotech vision that you want to turn into a market-ready application with a partner who is invested in your long-term growth, reach out to us at duke.lee@saram.io. Let’s build the future of life sciences together.